Pulmonary inflammation induced by bacteria-free outer membrane vesicles from Pseudomonas aeruginosa

American Journal of Respiratory Cell and Molecular Biology

Volumn 49, Issue 4, 2013, Pages 637-645

  Park, Kyong Su ^a   Lee, Jaewook ^a   Jang, Su Chul ^a   Kim, Sae Rom ^a   Jang, Myoung Ho ^a   Lötvall, Jan ^b   Kim, Yoon Keun ^a   Gho, Yong Song ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Exosomes; Infection; Pathogenicity; Pneumonia

Indexed keywords

CXCL1 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIUM CULTURE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG EXAMINATION; MALE; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CHEMOKINES; HUMANS; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; PNEUMONIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

EID: 84886622906     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0370OC     Document Type: Article

References (40)

1. Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:853-860.
2. Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med 2010;182:627-632.
3. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, Brockhurst MA, Winstanley C. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J Respir Crit Care Med 2011;183:1674-1679.
4. Brugha RE, Davies JC. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and new treatments. Br J Hosp Med (Lond) 2011;72: 614-619.
5. Kuehn MJ, Kesty NC. Bacterial outer membrane vesicles and the hostpathogen interaction. Genes Dev 2005;19:2645-2655.
6. Lee EY, Choi DS, Kim KP, Gho YS. Proteomics in Gram-negative bacterial outer membrane vesicles. Mass Spectrom Rev 2008;27:535-555.
7. Kulp A, Kuehn MJ. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol 2010;64:163-184.
8. Tashiro Y, Uchiyama H, Nomura N. Multifunctional membrane vesicles in Pseudomonas aeruginosa. Environ Microbiol 2012;14:1349-1362.
9. Lee EY, Bang JY, Park GW, Choi DS, Kang JS, Kim HJ, Park KS, Lee JO, Kim YK, Kwon KH, et al. Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics 2007;7:3143-3153.
10. Choi DS, Kim DK, Choi SJ, Lee J, Choi JP, Rho S, Park SH, Kim YK, Hwang D, Gho YS. Proteomic analysis of outer membrane vesicles derived from Pseudomonas aeruginosa. Proteomics 2011; 11:3424-3429.
11. Park KS, Choi KH, Kim YS, Hong BS, Kim OY, Kim JH, Yoon CM, Koh GY, Kim YK, Gho YS. Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS ONE 2010;5:e11334.
12. Kim JH, Yoon YJ, Lee J, Choi EJ, Yi N, Park KS, Park J, L'tvall J, Kim YK, Gho YS. Outer membrane vesicles derived from Escherichia coli up-regulate expression of endothelial cell adhesion molecules in vitro and in vivo. PLoS ONE 2013;8:e59276.
13. Kim DK, Kang BS, Kim OY, Choi DS, Lee J, Kim SR, Go G, Yoon YJ, Kim JH, Jang SC, et al. Evpedia: an integrated database of highthroughput data for systemic analyses of extracellular vesicles. J Extracellular Vesicles 2013;2:20384.
14. Ellis TN, Leiman SA, Kuehn MJ. Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components. Infect Immun 2010;78:3822-3831.
15. Bauman SJ, Kuehn MJ. Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes Infect 2006;8:2400-2408.
16. Bomberger JM, Ye S, Maceachran DP, Koeppen K, Barnaby RL, O'Toole GA, Stanton BA. A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system. PLoS Pathog 2011;7: e1001325.
17. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, Ernst S, Will O, Kaul R, Raymond C, Levy R, et al. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 2003;100:14339-14344.
18. Pugin J, Stern-Voeffray S, Daubeuf B, Matthay MA, Elson G, Dunn-Siegrist I. Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock. Blood 2004;104:4071-4079.
19. Moingeon P, Mascarell L. Novel routes for allergen immunotherapy: safety, efficacy and mode of action. Immunotherapy 2012;4:201-212.
20. O'Brien R, Ooi MA, Clarke AH, Thomas WR. Immunologic responses following respiratory sensitization to house dust mite allergens in mice. Immunol Cell Biol 1996;74:174-179.
21. Bomberger JM, Maceachran DP, Coutermarsh BA, Ye S, O'Toole GA, Stanton BA. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog 2009;5:e1000382.
22. Barnes PJ. The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2009;41:631-638.
23. Bhatia M, Zemans RL, Jeyaseelan S. Role of chemokines in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol 2012; 46:566-572.
24. Chung KF. Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Targets 2006;7:675-681.
25. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001;34:50s-59s.
26. Siwkowski AM, Madge LA, Koo S, McMillan EL, Monia BP, Pober JS, Baker BF. Effects of antisense oligonucleotide-mediated depletion of tumor necrosis factor (TNF) receptor 1-associated death domain protein on TNF-induced gene expression. Mol Pharmacol 2004;66: 572-579.
27. Rizzi C, Crippa MP, Jeeninga RE, Berkhout B, Blasi F, Poli G, Alfano M. Pertussis toxin B-oligomer suppresses IL-6 induced HIV-1 and chemokine expression in chronically infected U1 cells via inhibition of activator protein 1. J Immunol 2006;176:999-1006.
28. Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, Biolchi A, Brunelli B, Giuliani MM, Pizza M, Norais N, et al. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 2006;6:1856-1866.
29. McBroom AJ, Johnson AP, Vemulapalli S, Kuehn MJ. Outer membrane vesicle production by Escherichia coli is independent of membrane instability. J Bacteriol 2006;188:5385-5392.
30. Mug-Opstelten D,Witholt B. Preferential release of new outer membrane fragments by exponentially growing Escherichia coli. Biochim Biophys Acta 1978;508:287-295.
31. Zhou L, Srisatjaluk R, Justus DE, Doyle RJ. On the origin of membrane vesicles in gram-negative bacteria. FEMS Microbiol Lett 1998;163: 223-228.
32. McBroom AJ, Kuehn MJ. Release of outer membrane vesicles by Gramnegative bacteria is a novel envelope stress response. Mol Microbiol 2007;63:545-558.
33. Kadurugamuwa JL, Beveridge TJ. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J Bacteriol 1995;177:3998-4008.
34. Mashburn LM, Whiteley M. Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature 2005;437:422-425.
35. Lai CH, Listgarten MA, Hammond BF. Comparative ultrastructure of leukotoxic and non-leukotoxic strains of Actinobacillus actinomycetemcomitans. J Periodontal Res 1981;16:379-389.
36. Wai SN, Takade A, Amako K. The release of outer membrane vesicles from the strains of enterotoxigenic Escherichia coli. Microbiol Immunol 1995;39:451-456.
37. Cheluvappa R, Denning GM, Lau GW, Grimm MC, Hilmer SN, Le Couteur DG. Pseudomonas aeruginosa and the hyperlipidaemia of sepsis. Pathology 2009;41:615-621.
38. Kaul DR, Collins CD, Hyzy RC. New developments in antimicrobial use in sepsis. Curr Pharm Des 2008;14:1912-1920.
39. Tacconelli E, Tumbarello M, Bertagnolio S, Citton R, Spanu T, Fadda G, Cauda R. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology. Emerg Infect Dis 2002;8:220-221.
40. Shah B, Sullivan CJ, Lonergan NE, Stanley S, Soult MC, Britt LD. Circulating bacterial membrane vesicles cause sepsis in rats. Shock 2012;37:621-628.